The fourth Subject was safely treated with the low-dose of BB-301 in December 2024, and the fifth Subject was safely treated with the low-dose of BB-301 in early February 2025. The sixth Subject is ...
Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union (EU) and the United Kingdom (UK) for the first authorized use of an ...
The Colorado Kennel Club Dog Show is being held at the National Western Complex through Sunday. The youngest Trump doesn’t spend much time on campus, deepening the mystery surrounding who he really is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback